Emily E. Carr, PA

Emily Carr practices at Hill Country Memorial Hospital in Fredericksburg, Texas.

Emily Carr's NPI, 1548631641, was assigned on October 14, 2015. Emily Carr holds Texas license PA10065.

Emily Carr's primary practice is Hill Country Memorial Hospital, at 1020 S State Highway 16, Fredericksburg, TX 78624 in Gillespie County. The practice phone is (830) 997-4353.

Emily Carr's primary practice is Hill Country Memorial Hospital in Fredericksburg, Texas. Emily Carr is also affiliated with Peterson Regional Medical Center. The medical group on file is Sinus and ENT Center of Texas. Dmand AI also links Emily Carr to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Emily Carr practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Emily Carr's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Emily Carr is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Emily Carr is licensed in Texas.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, skin cyst, sleep apnea and swimmer's ear among the conditions Emily Carr treats.

CMS data shows 1,474 Medicare services from Emily Carr across 9 procedure codes in 2024, for 314 Medicare patients. Medicare paid $61,851 for them. Every service was in an office.

CMS counts 314 Medicare patients who saw Emily Carr in 2024. The largest group is 65 to 74, with 140 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Emily Carr's median patient age at 71, with 60% women.

In 2024, Emily Carr wrote 605 Medicare Part D claims for 229 patients. 91% of them were for generic drugs. CMS names the drug for 511 of them, across 13 drugs with 11 or more claims each, at $6,316 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Emily Carr for performance year 2024, reported as part of a group.

CMS Open Payments shows 19 general payments to Emily Carr from 4 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 82% of the total. Sanofi and Genzyme US Companies paid the most, $260.

Emily Carr is a member of AAPA.